UK - The Institute of Directors has launched a new qualification aimed at boosting corporate governance standards in the pharmaceutical industry.
The IoD’s Company Direction Programme will, for the first time, be tailored to the needs of industry leaders, covering directors’ responsibilities and strategies to improve business performance.
The diploma – a collaboration between the IoD and the Association of the British Pharmaceutical Industry – will also encourage the formation of a peer level network offering support to directors.
IoD director general George Cox said: “Pressure grows continuously for a high level of professionalism in the boardroom – the IoD’s Company Direction Programme is a major contributor towards equipping directors in this field.”
The programme is structured as a series of eight workshop modules, ranging from one to three days, to be taken over two years. Subjects covered include finance, law and marketing specifically in the context of the pharmaceutical industry, with completion of the diploma leading to eligibility for the IoD’s professional qualification, chartered director.
This week's edition of Professional Pensions is out now.
Ben Gunnee reflects on 2018 and talks about the Fiduciary Management trends to keep an eye on in 2019
Lloyds Banking Group secured 630,000 new pension customers last year, according to its 2018 annual results.
Guy Opperman has rejected calls to speed up changes to auto-enrolment (AE) despite increasing pressure to boost contribution rates and overall savings pots.